1 year return (CAGR)
27.85%
BridgeBio Pharma Inc Exchange (NASDAQ, USD)
BBIO
69.37
+1.22 (+1.79%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
41.34%
5 year return (CAGR)
8.02%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
13.56B
Price/Sales
19.60
Ent value
16.61B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
2522.55
EPS growth
-0.56%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 68.25 |
| Daily high | 69.64 |
| Daily low | 68.00 |
| Daily Volume | 2.04M |
| All-time high | 90.17 |
| 1y analyst estimate | 109.10 |
| Beta | 0.97 |
| EPS (TTM) | -3.56 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| BBIO | S&P500 | |
| Current price drop from All-time high | -23.07% | -1.21% |
| Highest price drop | -92.80% | -56.47% |
| Date of highest drop | 11 May 2022 | 9 Mar 2009 |
| Avg drop from high | -44.16% | -10.65% |
| Avg time to new high | 37 days | 12 days |
| Max time to new high | 1211 days | 1805 days |
News
